HighVista Strategies’s Ambrx Biopharma Inc AMAM Stock Holding History

HighVista Strategies’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-203,122	Closed	-$2.89M	–	165
2023 Q4	$2.89M	Buy	203,122 +9,421	+5%	+$107K	1.05%	30
2023 Q3	$2.23M	Buy	193,701 +40,270	+26%	+$548K	1.03%	25
2023 Q2	$2.53M	Buy	+153,431	New	+$1.93M	1.16%	28

HighVista Strategies's AMAM Position: Q1 2024 in Review

HighVista Strategies sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 203,122 shares — an estimated $2.89M sold.

HighVista Strategies first reported a position in AMAM in Q2 2023 and held it in 3 quarters. The position peaked at $2.89M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

HighVista Strategies reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
HighVista Strategies sold 203,122 Ambrx Biopharma Inc shares in Q1 2024, an estimated $2.89M.
HighVista Strategies first reported a position in Ambrx Biopharma Inc in Q2 2023 and held it in 3 quarters.
HighVista Strategies's Ambrx Biopharma Inc position peaked at $2.89M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on HighVista Strategies's 13F filing for Q1 2024, filed 15 May 2024.